About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Aifm1Hq
harlequin
MGI:1861097
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Aifm1Hq/Aifm1Hq B6CBACa Aw-J/A-Aifm1Hq/J MGI:2387325
hm2
Aifm1Hq/Aifm1Hq involves: CF-1 MGI:3699815
ht3
Aifm1Hq/Aifm1+ B6CBACa Aw-J/A-Aifm1Hq/J MGI:3707536
cx4
Aifm1Hq/Aifm1Hq
Apaf1Gt(IRESBetageo)XIX18Pgr/Apaf1Gt(IRESBetageo)XIX18Pgr
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA MGI:3699821
ot5
Aifm1Hq/Y B6CBACa Aw-J/A-Aifm1Hq/J MGI:2387326
ot6
Aifm1Hq/Y involves: CF-1 MGI:3699816


Genotype
MGI:2387325
hm1
Allelic
Composition
Aifm1Hq/Aifm1Hq
Genetic
Background
B6CBACa Aw-J/A-Aifm1Hq/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aifm1Hq mutation (2 available); any Aifm1 mutation (11 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• significantly reduced survival at both 1 and 4 weeks after transverse aortic banding
• about 30% of mice die during the first 6 months, with most deaths occurring between 15 and 30 days of age

growth/size/body
• hypertrophy due to transverse aorting banding is twice as great as is seen in controls
• body weight varies widely

behavior/neurological
• mice are protected against CA3 region damage at both 4 and 7 days after kainic acid induced stage 4 seizures although some cell damage is observed
• age of onset is approximately 5 months
• a perceptible lateral tremor at rest by 9 months of age
• age of onset is approximately 5 months of age (J:79052)
• mild (J:79052)
• truncal ataxia by 9 months (J:79052)
• ataxia is seen in most mice at 3 months of age and by 6 months of age, 90% of mice show severe ataxia while 8% have no signs of ataxia (J:144096)
• mice show impaired coordination on the rotarod from 4 months of age
• side by side unsteady gait at 5 months of age
• marked lateral swaying when moving and at rest by 9 months of age

nervous system
• mice are protected against CA3 region damage at both 4 and 7 days after kainic acid induced stage 4 seizures although some cell damage is observed
• resistant to cell death induced by glutamate, NMDA, and kainic acid
• Purkinje cell loss occurs later than granule cell loss (J:78983)
• cell loss apparently due to necrosis (J:78983)
• many Purkinje cells are dead by 7 months of age (J:78983)
• described as mild and patchy in the folia, but extensive in the floccular lobes in mice 5-8 months of age (J:79052)
• losses are preferentially from the caudal vermis and hemispheres (J:78983)
• most caudal granule cells are lost by 12 months (J:78983)
• no reduction in the folia but extensive loss in the floccular lobes in mice 5-8 months of age (J:79052)
• pyknotic granule cell nuclei at 4 months of age
• apoptotic granule cells seen at 4 months of age
• cerebellum normal before 3 months
• much smaller at 7 months
• cell loss is seen in the ganglion layer after about 3 months of age
• ganglion cell loss is seen after about 3 months of age
• ocular hypoplasia, with absence of the optic nerve in 40% of mice at 1 month of age

vision/eye
• cell loss is seen in the ganglion layer after about 3 months of age
• ganglion cell loss is seen after about 3 months of age
• ocular hypoplasia, with absence of the optic nerve in 40% of mice at 1 month of age
• thinning by 11 months
• thinning by 11 months
• onset of retinal degeneration is after 3 months of age
• cell loss is seen in all layers of the retina by 11 months
• both rod and cone ERG are diminished by 4 months of age
• ERG responses are completely abolished by 10 months of age

cellular
• cerebellar granule cells and retina cells re-enter the cell cycle with greater frequency than in controls
• number of cycling cells in the cerebellum and retina increase through 7 months and then declines
• granule cells of the cerebellum in culture show increased sensitivity to hydrogen peroxide
• greatly increased levels of both apoptosis and necrosis in myocytes after transverse aortic banding
• resistant to cell death induced by glutamate, NMDA, and kainic acid
• respiratory chain complex I deficiency is detected at 1 month of age and is seen in the cerebellum, thalamus, cortical-enriched brain fractions, optic nerves, and retinas at 6 months of age, with activity about 50% of wild-type levels in the cerebellum
• respiratory chain complex I activity is reduced by 20% in the spinal cord, by 10% in kidney, and by 30% in skeletal muscle and is normal in heart, liver, and testis
• complex I deficiency is greatest by 1 month of age in the cerebellum and skeletal muscle, while it is modest or absent in the thalamus, cortex, and optic nerve at 1 month of age and reaches 50% by 6 months of age
• increased sensitivity of the cerebellum to oxidative stress (J:78983)
• oxidative damage to mitochondria of the cerebellar granular layer and the ganglion layer of the retina (J:78983)
• slightly increased as a result of transverse aortic banding (J:110278)

cardiovascular system
• hypertrophy due to transverse aorting banding is twice as great as is seen in controls
• increased left ventricular internal diameter relative to controls as a result of transverse aortic banding
• deterioration of cardiac contractility as a result of transverse aortic banding
• cardiomyocytes more prone to die in response to exposure to hydrogen peroxide
• increased sensitivity to ischemia/reperfusion injury
• over 80% fail to survive 30minutes of left anterior descending artery occlusion followed by 2 to 24 hours of reperfusion
• experimental infarction size is increased by 50% over controls in 2 month old animals and by 78% in 6 month old animals
• apoptosis in viable muscle cells is also increased

muscle
• deterioration of cardiac contractility as a result of transverse aortic banding
• greatly increased levels of both apoptosis and necrosis in myocytes after transverse aortic banding

homeostasis/metabolism
• increased sensitivity to ischemia/reperfusion injury
• over 80% fail to survive 30minutes of left anterior descending artery occlusion followed by 2 to 24 hours of reperfusion
• experimental infarction size is increased by 50% over controls in 2 month old animals and by 78% in 6 month old animals
• apoptosis in viable muscle cells is also increased
• resistant to cell death induced by glutamate, NMDA, and kainic acid
• mice exhibit moderately elevated superoxide dismutase activities at 6 months of age in skeletal muscle
• catalase activity increased in the cerebellum at 1 and 3 months of age (J:78983)
• mice exhibit moderately elevated catalase activities at 6 months of age in skeletal muscle (J:144096)

integument
• complete baldness in most mice initially, followed by some hair growth resulting in a patchy or near-normal coat
• at 3 months of age, about 50% of mice are bald over more than 30% of their body and about 30% have near-normal fur, and 10% of mice have near-normal fur at 6 months of age
• described as nearly bald

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
mitochondrial complex I deficiency DOID:0060536 J:144096




Genotype
MGI:3699815
hm2
Allelic
Composition
Aifm1Hq/Aifm1Hq
Genetic
Background
involves: CF-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aifm1Hq mutation (2 available); any Aifm1 mutation (11 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• adults are about 1/3 the weight of controls

integument
• mice have bald patches of varying extent and distribution




Genotype
MGI:3707536
ht3
Allelic
Composition
Aifm1Hq/Aifm1+
Genetic
Background
B6CBACa Aw-J/A-Aifm1Hq/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aifm1Hq mutation (2 available); any Aifm1 mutation (11 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Aifm1Hq/+ female

behavior/neurological
N
• heterozygotes are normal with respect to ataxia

integument
• patchy irregular hair loss

nervous system
N
• no loss of granule cells seen to 26 months of age




Genotype
MGI:3699821
cx4
Allelic
Composition
Aifm1Hq/Aifm1Hq
Apaf1Gt(IRESBetageo)XIX18Pgr/Apaf1Gt(IRESBetageo)XIX18Pgr
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aifm1Hq mutation (2 available); any Aifm1 mutation (11 available)
Apaf1Gt(IRESBetageo)XIX18Pgr mutation (1 available); any Apaf1 mutation (78 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• reduced apoptosis of cultured cortical neurons resulting from treatment with camptothecin
• neurons show enhanced viability when treated with camptothecin
• only about half of dying cells exhibit DNA fragmentation

cellular
• reduced apoptosis of cultured cortical neurons resulting from treatment with camptothecin
• neurons show enhanced viability when treated with camptothecin
• only about half of dying cells exhibit DNA fragmentation




Genotype
MGI:2387326
ot5
Allelic
Composition
Aifm1Hq/Y
Genetic
Background
B6CBACa Aw-J/A-Aifm1Hq/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aifm1Hq mutation (2 available); any Aifm1 mutation (11 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• significantly reduced survival at both 1 and 4 weeks after transverse aortic banding
• about 30% of mice die during the first 6 months, with most deaths occurring between 15 and 30 days of age

growth/size/body
• hypertrophy due to transverse aorting banding is twice as great as is seen in controls
• body weight varies widely
• at 1 month of age, about half of the males show growth retardation with a greater than 30% decrease in body weight
• however, about 30% of males at 6 months of age do not show any growth retardation

behavior/neurological
• mice are protected against CA3 region damage at both 4 and 7 days after kainic acid induced stage 4 seizures although some cell damage is observed
• age of onset is approximately 5 months
• a perceptible lateral tremor at rest by 9 months of age
• mild (J:79052)
• age of onset is approximately 5 months of age (J:79052)
• truncal ataxia by 9 months (J:79052)
• ataxia is seen in most mice at 3 months of age and by 6 months of age, 90% of mice show severe ataxia while 8% have no signs of ataxia (J:144096)
• mice show impaired coordination on the rotarod from 4 months of age
• side by side unsteady gait at 5 months of age
• marked lateral swaying when moving and at rest by 9 months of age

nervous system
• mice are protected against CA3 region damage at both 4 and 7 days after kainic acid induced stage 4 seizures although some cell damage is observed
• resistant to cell death induced by glutamate, NMDA, and kainic acid
• Purkinje cell loss occurs later than granule cell loss (J:78983)
• cell loss apparently due to necrosis (J:78983)
• many Purkinje cells are dead by 7 months of age (J:78983)
• described as mild and patchy in the folia, but extensive in the floccular lobes in mice 5-8 months of age (J:79052)
• losses are preferentially from the caudal vermis and hemispheres (J:78983)
• most caudal granule cells are lost by 12 months (J:78983)
• no reduction in the folia but extensive loss in the floccular lobes in mice 5-8 months of age (J:79052)
• pyknotic granule cell nuclei at 4 months of age
• apoptotic granule cells seen at 4 months of age
• much smaller at 7 months
• cerebellum normal before 3 months
• cell loss is seen in the ganglion layer after 3 months of age
• ganglion cell loss is seen after about 3 months of age
• ocular hypoplasia, with absence of the optic nerve in 40% of mice at 1 month of age

vision/eye
• cell loss is seen in the ganglion layer after 3 months of age
• ganglion cell loss is seen after about 3 months of age
• ocular hypoplasia, with absence of the optic nerve in 40% of mice at 1 month of age
• thinning by 11 months
• thinning by 11 months
• onset of retinal degeneration is after 3 months of age
• cell loss is seen in all layers of the retina by 11 months
• both rod and cone ERG are diminished by 4 months of age
• ERG responses are completely abolished by 10 months of age

cellular
• cerebellar granule cells and retina cells re-enter the cell cycle with greater frequency than in controls
• number of cycling cells in the cerebellum and retina increase through 7 months and then declines
• granule cells of the cerebellum in culture show increased sensitivity to hydrogen peroxide
• greatly increased levels of both apoptosis and necrosis in myocytes after transverse aortic banding
• resistant to cell death induced by glutamate, NMDA, and kainic acid
• respiratory chain complex I deficiency is detected at 1 month of age and is seen in the cerebellum, thalamus, cortical-enriched brain fractions, optic nerves, and retinas at 6 months of age, with activity about 50% of wild-type levels in the cerebellum
• respiratory chain complex I activity is reduced by 20% in the spinal cord, by 10% in kidney, and by 30% in skeletal muscle and is normal in heart, liver, and testis
• complex I deficiency is greatest by 1 month of age in the cerebellum and skeletal muscle, while it is modest or absent in the thalamus, cortex, and optic nerve at 1 month of age and reaches 50% by 6 months of age
• increased sensitivity of the cerebellum to oxidative stress (J:78983)
• oxidative damage to mitochondria of the cerebellar granular layer and the ganglion layer of the retina (J:78983)
• slightly increased as a result of transverse aortic banding (J:110278)

cardiovascular system
• hypertrophy due to transverse aorting banding is twice as great as is seen in controls
• increased left ventricular internal diameter relative to controls as a result of transverse aortic banding
• deterioration of cardiac contractility as a result of transverse aortic banding
• cardiomyocytes more prone to die in response to exposure to hydrogen peroxide
• increased sensitivity to ischemia/reperfusion injury
• over 80% fail to survive 30minutes of left anterior descending artery occlusion followed by 2 to 24 hours of reperfusion
• experimental infarction size is increased by 50% over controls in 2 month old animals and by 78% in 6 month old animals
• apoptosis in viable muscle cells is also increased

muscle
• deterioration of cardiac contractility as a result of transverse aortic banding
• greatly increased levels of both apoptosis and necrosis in myocytes after transverse aortic banding

homeostasis/metabolism
• increased sensitivity to ischemia/reperfusion injury
• over 80% fail to survive 30minutes of left anterior descending artery occlusion followed by 2 to 24 hours of reperfusion
• experimental infarction size is increased by 50% over controls in 2 month old animals and by 78% in 6 month old animals
• apoptosis in viable muscle cells is also increased
• resistant to cell death induced by glutamate, NMDA, and kainic acid
• mice exhibit moderately elevated superoxide dismutase activities at 6 months of age in skeletal muscle
• catalase activity increased in the cerebellum at 1 and 3 months of age (J:78983)
• mice exhibit moderately elevated catalase activities at 6 months of age in skeletal muscle (J:144096)

integument
• complete baldness in most mice initially, followed by some hair growth resulting in a patchy or near-normal coat
• at 3 months of age, about 50% of mice are bald over more than 30% of their body and about 30% have near-normal fur, and 10% of mice have near-normal fur at 6 months of age
• described as nearly bald

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
mitochondrial complex I deficiency DOID:0060536 J:144096




Genotype
MGI:3699816
ot6
Allelic
Composition
Aifm1Hq/Y
Genetic
Background
involves: CF-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aifm1Hq mutation (2 available); any Aifm1 mutation (11 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• adults are about 1/3 the weight of controls

integument
• mice have bald patches of varying extent and distribution





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory